Brookfield Asset Management Inc. Viatris Inc Transaction History

Brookfield Asset Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$8.72 - $11.56 $2.13 Million - $2.82 Million	-244,049 Reduced 21.69%	881,201 $9.81 Million
Q3 2022 Nov 14, 2022	BUY	$8.48 - $11.13 $9.54 Million - $12.5 Million	1,125,250 New	1,125,250 $9.59 Million
Q1 2022 May 16, 2022	BUY	$9.81 - $15.4 $3.73 Million - $5.85 Million	379,910 Added 172.73%	599,854 $6.53 Million
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $3.15 Million - $4.12 Million	219,944 New	219,944 $4.12 Million

1,095

965M

2.69M

2.34M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.7B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.